Kraig Biocraft Laboratories, Inc. KBLB
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.39M | 2.89M | 1.79M | 1.57M | 785.50K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | 134.10K | 74.30K | 29.10K | 29.10K | 6.90K |
| Prepaid Expenses | 49.10K | 45.20K | 49.30K | 45.20K | 46.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 3.57M | 3.01M | 1.87M | 1.64M | 839.00K |
|
|
|||||
| Total Current Assets | 3.57M | 3.01M | 1.87M | 1.64M | 839.00K |
| Net Property, Plant & Equipment | 246.30K | 189.50K | 195.50K | 215.00K | 95.40K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 10.00K | 7.20K | 7.20K | 7.20K | 7.20K |
| Total Assets | 4.27M | 3.72M | 2.57M | 2.36M | 1.59M |
|
|
|||||
| Total Accounts Payable | 807.60K | 825.40K | 808.40K | 793.90K | 826.00K |
| Total Accrued Expenses | 8.53M | 8.31M | 8.09M | 7.77M | 7.56M |
| Short-term Debt | 1.49M | 1.49M | 1.49M | 1.57M | 1.62M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 72.80K | 51.60K | 51.90K | 56.10K | 24.30K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 10.90M | 10.68M | 10.45M | 10.18M | 10.03M |
|
|
|||||
| Total Current Liabilities | 10.90M | 10.68M | 10.45M | 10.18M | 10.03M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1.49M | 1.49M | 1.49M | 1.57M | 1.62M |
| Capital Leases | 121.20K | 106.40K | 119.30K | 128.00K | 34.50K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 11.02M | 10.78M | 10.56M | 10.31M | 10.06M |
|
|
|||||
| Common Stock & APIC | 46.55M | 45.33M | 43.45M | 42.71M | 40.68M |
| Retained Earnings | -58.56M | -57.65M | -56.71M | -55.92M | -54.41M |
| Treasury Stock & Other | 22.00K | 22.00K | 22.00K | 22.00K | 22.00K |
| Total Common Equity | -11.99M | -12.30M | -13.24M | -13.19M | -13.71M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 5.24M | 5.24M | 5.24M | 5.24M | 5.24M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 5.24M | 5.24M | 5.24M | 5.24M | 5.24M |
|
|
|||||
| Total Common Equity | -11.99M | -12.30M | -13.24M | -13.19M | -13.71M |
| Total Preferred Equity | 5.24M | 5.24M | 5.24M | 5.24M | 5.24M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -6.75M | -7.06M | -8.00M | -7.96M | -8.47M |
|
|
|||||